Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04421820
Title BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bold Therapeutics, Inc.
Indications

colorectal cancer

stomach cancer

cholangiocarcinoma

pancreatic cancer

gastrointestinal system cancer

Therapies

BOLD-100 + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institue Recruiting Edmonton Alberta T6G1Z2 Canada Details
Juravinski Cancer Centre Recruiting Hamilton Ontario L8V 5C2 Canada Details
The Ottawa Hospital Cancer Centre Recruiting Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Centre Recruiting Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital Recruiting Montreal Quebec H3T 1E2 Canada Details
McGill University Health Centre Glen Site Recruiting Montréal Quebec H4A 3J1 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field